Cancerify Logo
Log inSign up
Back to clinical trials
RecruitingInterventionalPhase 3

A Phase III Randomized Trial for Newly Diagnosed Multiple Myeloma (NDMM) Patients Considered Frail or in a Subset of "Intermediate Fit" Comparing Upfront Three-Drug Induction Regimens Followed by Double or Single-Agent Maintenance

NCT ID: NCT05561387Sponsor: SWOG Cancer Research NetworkLast updated: 2026-06-10

Summary

This phase III trial compares three-drug induction regimens followed by double-or single-drug maintenance therapy for the treatment of newly diagnosed multiple myeloma in patients who are not receiving a stem cell transplant and are considered frail or intermediate-fit based on age, comorbidities, and functional status. Treatment for multiple myeloma includes initial treatment (induction) which is the first treatment a patient receives for cancer followed by ongoing treatment (maintenance) which is given after initial treatment to help keep the cancer from coming back. There are three combinations of four different drugs being studied. Bortezomib is one of the drugs that may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Lenalidomide works by helping bone marrow to produce normal blood cells and killing cancer cells. Anti-inflammatory drugs, such as dexamethasone, lower the body's immune response and are used with other drugs in the treatment of some types of cancer. Daratumumab and hyaluronidase-fihj is a monoclonal antibody that may interfere with the ability of cancer cells to grow and spread. Patients receive 1 of 3 combinations of these drugs for treatment to determine which combination of study drugs works better to shrink and control multiple myeloma.

Detailed description

PRIMARY OBJECTIVES: I. To compare progression-free survival (PFS) in frail or selected intermediate fit newly diagnosed multiple myeloma (NDMM) participants treated with bortezomib with lenalidomide and dexamethasone at reduced dosing (VRd-Lite) induction followed by lenalidomide maintenance (Arm 1) versus daratumumab and hyaluronidase-fihj with lenalidomide and dexamethasone (DRd) induction followed by lenalidomide maintenance (Arm 2). II. To compare overall survival (OS) in frail or selected intermediate fit NDMM participants treated with VRd-Lite induction followed by lenalidomide maintenance (Arm 1) versus DRd induction followed by lenalidomide and daratumumab and hyaluronidase-fihj maintenance (Arm 3). SECONDARY OBJECTIVES: I. To compare PFS in Arm 1 versus Arm 3 II. To compare OS in Arm 1 versus Arm 2. III. To compare PFS in Arm 2 versus 3. IV. To compare the overall response rate (ORR) of Arm 1 against the ORR of Arm 2 and Arm 3. V. To compare the safety of Arm 1 with the safety of Arm 2 and Arm 3. VI. To explore veinous thrombo-embolism (VTE) incidence in participants receiving lenalidomide during induction across the three study arms. VII. To describe median time to response (complete response \[CR\] or better per International Myeloma Working Group \[IMWG\] criteria, very good partial response \[VGPR\] or better per IMWG criteria, partial response \[PR\] or better per IMWG criteria) on the three study arms. PRIMARY QUALITY OF LIFE (QOL) OBJECTIVE: I. To compare patient-reported global health status between treatment arms (Arm 1 versus the combination of Arms 2 and 3) at 9 months after randomization (end of induction therapy) using the European Organization for Research and Treatment of Cancer (EORTC) Core Quality of Life Questionnaire (QLQ-C30). SECONDARY QOL OBJECTIVE: II. To compare longitudinal changes in global health status between treatment arms (Arm 1 versus the combination of Arms 2 and 3) from baseline to 9 months after randomization (end of induction therapy). PATIENT REPORTED OUTCOMES-COMMON TERMINOLOGY CRITERIA FOR ADVERSE EVENTS (PRO-CTCAE) OBJECTIVE: I. To compare selected patient-reported outcome symptoms using PRO-CTCAE items among the 3 study arms. ADDITIONAL OBJECTIVES: I. To compare the rate of minimal residual disease (MRD) by clonoSEQ after 9 cycles of induction in Arm 1 versus Arm 2 and Arm 3, respectively. II. To compare the rate of MRD conversion after 1 year of maintenance in participants who were MRD positive after induction in Arm 1 versus Arm 2 and Arm 3, respectively. III. To compare the rate of sustained MRD negativity at time points of post-induction, post-1 year maintenance in Arm 1 versus Arm 2 and Arm 3, respectively. BANKING OBJECTIVES: I. To bank specimens for future correlative studies. OUTLINE: Patients are randomized to 1 of 3 arms. ARM I (VRd-Lite): INDUCTION CYCLES 1-9: Patients receive bortezomib subcutaneously (SC) on days 1, 8, 15, and 22 of each cycle, lenalidomide orally (PO) on days 1-21 of each cycle, and dexamethasone PO on days 1, 8, 15, and 22 of each cycle. Treatment repeats every 28 days for up to 9 cycles in the absence of disease progression or unacceptable toxicity. MAINTENANCE CYCLES 10+: Patients receive lenalidomide PO on days 1-21 of each cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. ARM II (DRd-R): INDUCTION CYCLES 1-9: Patients receive daratumumab and hyaluronidase-fihj SC on days 1, 8, 15, and 22 of cycles 1-2, days 1 and 15 of cycles 3-6, and day 1 of cycles 7-9, lenalidomide PO on days 1-21 of each cycle, and dexamethasone PO on days 1, 8, 15, and 22 of each cycle. Treatment repeats every 28 days for up to 9 cycles in the absence of disease progression or unacceptable toxicity. MAINTENANCE CYCLES 10+: Patients receive lenalidomide PO on days 1-21 of each cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. ARM III (DRd-DR): INDUCTION CYCLES 1-9: Patients receive daratumumab and hyaluronidase-fihj SC on days 1, 8, 15, and 22 of cycles 1-2, days 1 and 15 of cycles 3-6, and day 1 of cycles 7-9, lenalidomide PO on days 1-21 of each cycle, and dexamethasone PO on days 1, 8, 15, and 22 of each cycle. Treatment repeats every 28 days for up to 9 cycles in the absence of disease progression or unacceptable toxicity. MAINTENANCE CYCLES 10+: Patients receive daratumumab and hyaluronidase-fihj SC on day 1 of each cycle and lenalidomide PO on days 1-21 of each cycle. Cycles repeat every 28 days in the absence of disease progression or unacceptable toxicity. After completion of study treatment, patients are followed up every 3 months for 1 year, every 6 months for 2 years, and then annually for up to 10 years.

Arms & interventions

  • DrugBortezomib

    Given SC

  • DrugDaratumumab and Hyaluronidase-fihj

    Given SC

  • DrugDexamethasone

    Given PO

  • DrugLenalidomide

    Given PO

  • OtherQuality-of-Life Assessment

    Ancillary studies

  • OtherQuestionnaire Administration

    Ancillary studies

Outcome measures

Primary

  • Progression free survival (PFS) of Arm 1 versus (vs.) Arm 2

    Analysis of each of the dual primary endpoints will be performed using a stratified log-rank test for comparison between arms. The analyses will be stratified according to frailty score (frail vs. intermediate fit), presence of one or more high-risk abnormalities by fluorescence in situ hybridization (iFISH) (yes vs. no), and prior therapy (yes vs. no). All eligible participants will be considered in analyses of the dual primary endpoints, according to their assigned arm at randomization.

    Time frame: From date of randomization to date of first documentation of progression or symptomatic deterioration, or death due to any cause, or assessed up to 10 years

  • Overall survival (OS) of Arm 1 vs. Arm 3

    Analysis of each of the dual primary endpoints will be performed using a stratified log-rank test for comparison between arms. The analyses will be stratified according to frailty score (frail vs. intermediate fit), presence of one or more high-risk abnormalities by iFISH (yes vs. no), and prior therapy (yes vs. no). All eligible participants will be considered in analyses of the dual primary endpoints, according to their assigned arm at randomization.

    Time frame: From date of randomization to date of death due to any cause, or assessed up to 10 years

Secondary

  • PFS

    Time frame: From date of randomization to date of first documentation of progression or symptomatic deterioration, or death due to any cause, or assessed up to 10 years

  • OS

    Time frame: From date of randomization to date of death due to any cause, or assessed up to 10 years

  • Overall response rate (ORR)

    Time frame: Up to 10 years

  • Time to complete response (CR)

    Time frame: The time from the date of registration to the date of the first documented incidence of a response of CR or better, assessed up to 10 years

  • Time to very good partial response (VGFR)

    Time frame: The time from the date of registration to the date of the first documented incidence of a response of VGPR or better, assessed up to 10 years

  • Time to PR

    Time frame: The time from the date of registration to the date of the first documented incidence of a response of PR or better, assessed up to 10 years

  • Minimal residual disease (MRD)

    Time frame: At 9 months of induction therapy and 1 year of maintenance therapy

  • Patient report out comes (PRO) quality-of-life (QOL)

    Time frame: At baseline and months 1, 3, 9, and 18 after randomization

  • Patient-reported toxicity (PRO-Common Terminology Criteria for Adverse Events [CTCAE])

    Time frame: At baseline, at each treatment cycle up to month 18 from randomization, and at discontinuation of treatment

Eligibility criteria

Sex: AllAge: All agesHealthy volunteers: No
Inclusion Criteria: * Participants must have documented multiple myeloma satisfying standard International Myeloma Working Group (IMWG) diagnostic criteria within 28 days prior to registration * Participants must have measurable disease within 28 days prior to registration as defined by any of the following: * Immunoglobulin (Ig) G myeloma (serum monoclonal paraprotein \[M-protein\] level \>= 0.5 gram/deciliter \[g/dL\] or urine M-protein level \>= 200 milligram\[mg\]/24 hours\[hrs\]); OR * IgA, IgM, IgD, or IgE multiple myeloma (serum M-protein level \>= 0.2 g/dL or urine M-protein level \>= 200 mg/24 hrs); OR * Light chain multiple myeloma (serum immunoglobulin free light chain \>= 10 mg/dL and abnormal serum immunoglobulin kappa lambda free light chain ratio) * All disease must be assessed and documented on the baseline/pre-registration tumor assessment form * Participants must have a calculated myeloma frailty index (Myeloma Frailty Score Calculator; http://www.myelomafrailtyscorecalculator.net/) categorized as frail or intermediate fit (regardless of age) within 28 days prior to registration * For Participants Meeting "Frail" Status: * Participants with any degree of kidney dysfunction are allowed; however, participants on dialysis are not eligible * For Participants Meeting "Frail" Status: * Hemoglobin \>= 7 g/dL (must be performed within 28 days prior to registration) * Note: growth factor and transfusion utilization are allowed if cytopenias are considered secondary to bone marrow involvement from MM) * For Participants Meeting "Frail" Status: * Platelets \>= 50 x 10\^9/L (must be performed within 28 days prior to registration) * Note: growth factor and transfusion utilization are allowed if cytopenias are considered secondary to bone marrow involvement from MM) * For Participants Meeting "Frail" Status: * Absolute neutrophil count (ANC) \>= 0.75 x10\^9/L (must be performed within 28 days prior to registration) * Note: growth factor and transfusion utilization are allowed if cytopenias are considered secondary to bone marrow involvement from MM) * For Participants Meeting "Intermediate Fit" Status, one or more of the following criteria must be present: * Kidney dysfunction showing calculated creatinine clearance (CrCl) \<30 ml/min. * Actual lab serum creatinine value with a minimum of 0.7 mg/dL. * Participants must have bone marrow function assessed and meet the below criteria ranges: * Hemoglobin between 7-8 g/dL, OR * Platelets between 50-75 x10\^9/L, OR * ANC between 0.75-1 x10\^9/L * Note: growth factor and transfusion utilization are allowed as long as cytopenias are considered secondary to bone marrow involvement from MM) * Revised International Staging System (R-ISS) stage III disease * Note: All labs must be performed within 28 days prior to registration * Participants must have a complete medical history and physical exam within 28 days prior to registration * Participants must have whole body imaging within 60 days prior to registration. The recommended method of imaging is a positron emission tomography/computed tomography (PET/CT); a low-dose whole body CT scan or whole-body magnetic resonance imaging (MRI) or skeletal survey should be done only if a PET/CT scan cannot be done or is non-feasible. This must be documented in the comments section of the Onstudy form. * Total bilirubin =\< 2 times institutional upper limit of normal (ULN) unless history of Gilbert's disease. Participants with history of Gilbert's disease must have total bilirubin =\< 5 x institutional ULN (within 28 days prior to registration) * Aspartate aminotransferase (AST)/alanine aminotransferase (ALT) =\< 3 × institutional ULN (within 28 days prior to registration) * Participants must have adequate cardiac function, as assessed by the treating physician within 14 days prior to registration. Participants with known history or current symptoms of cardiac disease, or history of treatment with cardiotoxic agents, must have a clinical risk assessment of cardiac function using the New York Heart Association Functional Classification and must not be assessed as class 3 or 4 * Participants with known diabetes must show evidence of controlled disease within 14 days prior to registration. Uncontrolled diabetes is defined as: A glycosylated hemoglobin (Hg)A1C \> 7 * Participants with known human immunodeficiency virus (HIV)-infection must be receiving anti-retroviral therapy and have an undetectable viral load test on the most recent test result obtained, within 6 months prior to registration * All participants with evidence of chronic hepatitis B virus (HBV) infection must have undetectable HBV viral load on suppressive therapy within 28 days prior to registration * Participants with a history of hepatitis C virus (HCV) infection must have been treated and cured. For participants with HCV infection who are currently on treatment, participant must have an undetectable HCV viral load within 28 days prior to registration * Participants must have an Eastern Cooperative Oncology Group (ECOG)/Zubrod performance status score of 0-2 (Note: Participants with ECOG/Zubrod performance score \[PS\] 3, especially where the deterioration of PS is considered secondary to the MM diagnosis, will be allowed) * Participants must be offered the opportunity to participate in specimen banking. With participant consent, specimens must be collected and submitted via the Southwest Oncology Group (SWOG) specimen tracking system * Participants who are able to complete the patient-reported outcomes measures in English or Spanish must agree to participate in the PRO portion of the study * Participants must be informed of the investigational nature of this study and must sign and give informed consent in accordance with institutional and federal guidelines. For participants with impaired decision-making capabilities, legally authorized representatives may sign and give informed consent on behalf of study participants in accordance with applicable federal, local, and Central Institutional Review Board (CIRB) regulations Exclusion Criteria: * Participants must not have received any prior systemic therapy for multiple myeloma with the exception of any one or more of the following: * An emergency use of a short course of corticosteroids (equivalent of dexamethasone 160 mg) any time before registration, or * Up to one complete cycle of a non-daratumumab and hyaluronidase-fihj containing anti-myeloma regimen (1 cycle = 21 or 28 days depending on the regimen being used), or * Localized palliative radiation therapy for multiple myeloma, as long as the radiation therapy is completed at least 3 days prior to starting the systemic treatment as per the study protocol. * Participants must not have evidence of grade 4 peripheral neuropathy prior to study registration * Participants must not have uncontrolled blood pressure within 14 days prior to registration. Uncontrolled blood pressure: systolic blood pressure (SBP) \> 140 mmHg or diastolic blood pressure (DBP) \> 90 mmHg. Participants are permitted to be receiving multiple anti-hypertensive medications (unless otherwise indicated in the study). All blood pressure measurements within the 14 days prior to registration must be SBP =\< 140 and DBP =\< 90. A participant with a single blood pressure elevation who upon rechecking has a normal blood pressure will remain eligible at the discretion of the registering investigator. * Participants must not have a prior or concurrent malignancy whose natural history or treatment (in the opinion of the treating physician) has the potential to interfere with the safety or efficacy assessment of the investigational regimen. * Participants must not be pregnant or nursing. Individuals who are of reproductive potential must have agreed to use an effective contraceptive method with details provided as a part of the consent process. A person who has had menses at any time in the preceding 24 consecutive months or who has semen likely to contain sperm is considered to be of "reproductive potential." In addition to routine contraceptive methods, "effective contraception" also includes refraining from sexual activity that might result in pregnancy and surgery intended to prevent pregnancy (or with a side-effect of pregnancy prevention) including hysterectomy, bilateral oophorectomy, bilateral tubal ligation/occlusion, and vasectomy with testing showing no sperm in the semen.

Study locations (397)

Anchorage Associates in Radiation Medicine

Anchorage, Alaska, 98508

Recruiting
Charles W. Drescher · Principal Investigator

Anchorage Radiation Therapy Center

Anchorage, Alaska, 99504

Recruiting
Charles W. Drescher · Principal Investigator

Alaska Breast Care and Surgery LLC

Anchorage, Alaska, 99508

Recruiting
Charles W. Drescher · Principal Investigator

Alaska Oncology and Hematology LLC

Anchorage, Alaska, 99508

Recruiting
Charles W. Drescher · Principal Investigator

Alaska Women's Cancer Care

Anchorage, Alaska, 99508

Recruiting
Charles W. Drescher · Principal Investigator

Anchorage Oncology Centre

Anchorage, Alaska, 99508

Recruiting
Charles W. Drescher · Principal Investigator

Katmai Oncology Group

Anchorage, Alaska, 99508

Recruiting
Charles W. Drescher · Principal Investigator

Providence Alaska Medical Center

Anchorage, Alaska, 99508

Recruiting
Charles W. Drescher · Principal Investigator

Cancer Center at Saint Joseph's

Phoenix, Arizona, 85004

Recruiting
Shahzad Siddique · Principal Investigator

Mercy Hospital Fort Smith

Fort Smith, Arkansas, 72903

Recruiting
Site Public Contact · Contact
Jay W. Carlson · Principal Investigator

CARTI Cancer Center

Little Rock, Arkansas, 72205

Recruiting
Site Public Contact · Contact
Jay W. Carlson · Principal Investigator

John L McClellan Memorial Veterans Hospital

Little Rock, Arkansas, 72205

Suspended

University of Arkansas for Medical Sciences

Little Rock, Arkansas, 72205

Recruiting
Site Public Contact · Contact
Samer Al Hadidi · Principal Investigator

Mission Hope Medical Oncology - Arroyo Grande

Arroyo Grande, California, 93420

Recruiting
Shahzad Siddique · Principal Investigator

Providence Saint Joseph Medical Center/Disney Family Cancer Center

Burbank, California, 91505

Recruiting
Site Public Contact · Contact
Charles W. Drescher · Principal Investigator

Marshall Cancer Center

Cameron Park, California, 95682

Recruiting
Aaron Rosenberg · Principal Investigator

Mercy Cancer Center - Carmichael

Carmichael, California, 95608

Recruiting
Shahzad Siddique · Principal Investigator

Mercy San Juan Medical Center

Carmichael, California, 95608

Recruiting
Shahzad Siddique · Principal Investigator

Mercy Cancer Center - Elk Grove

Elk Grove, California, 95758

Recruiting
Shahzad Siddique · Principal Investigator

Fremont - Rideout Cancer Center

Marysville, California, 95901

Recruiting
Site Public Contact · Contact
Aaron Rosenberg · Principal Investigator

Mercy UC Davis Cancer Center

Merced, California, 95340

Recruiting
Shahzad Siddique · Principal Investigator

Providence Queen of The Valley

Napa, California, 94558

Recruiting
Site Public Contact · Contact
Charles W. Drescher · Principal Investigator

Mercy Cancer Center - Rocklin

Rocklin, California, 95765

Recruiting
Shahzad Siddique · Principal Investigator

Mercy Cancer Center - Sacramento

Sacramento, California, 95816

Recruiting
Shahzad Siddique · Principal Investigator

University of California Davis Comprehensive Cancer Center

Sacramento, California, 95817

Recruiting
Site Public Contact · Contact
Aaron Rosenberg · Principal Investigator

Pacific Central Coast Health Center-San Luis Obispo

San Luis Obispo, California, 93401

Recruiting
Shahzad Siddique · Principal Investigator

Mission Hope Medical Oncology - Santa Maria

Santa Maria, California, 93444

Recruiting
Shahzad Siddique · Principal Investigator

Providence Medical Foundation - Santa Rosa

Santa Rosa, California, 95403

Recruiting
Site Public Contact · Contact
Charles W. Drescher · Principal Investigator

Providence Santa Rosa Memorial Hospital

Santa Rosa, California, 95405

Recruiting
Site Public Contact · Contact
Charles W. Drescher · Principal Investigator

Gene Upshaw Memorial Tahoe Forest Cancer Center

Truckee, California, 96161

Recruiting
Site Public Contact · Contact
Aaron Rosenberg · Principal Investigator

Woodland Memorial Hospital

Woodland, California, 95695

Recruiting
Shahzad Siddique · Principal Investigator

Rocky Mountain Regional VA Medical Center

Aurora, Colorado, 80045

Recruiting
Site Public Contact · Contact
Jessica D. McDermott · Principal Investigator

Penrose-Saint Francis Healthcare

Colorado Springs, Colorado, 80907

Recruiting
Shahzad Siddique · Principal Investigator

Rocky Mountain Cancer Centers-Penrose

Colorado Springs, Colorado, 80907

Recruiting
Shahzad Siddique · Principal Investigator

Saint Francis Cancer Center

Colorado Springs, Colorado, 80923

Recruiting
Shahzad Siddique · Principal Investigator

Porter Adventist Hospital

Denver, Colorado, 80210

Suspended

Mercy Medical Center

Durango, Colorado, 81301

Recruiting
Shahzad Siddique · Principal Investigator

Southwest Oncology PC

Durango, Colorado, 81301

Recruiting
Shahzad Siddique · Principal Investigator

Saint Anthony Hospital

Lakewood, Colorado, 80228

Recruiting
Shahzad Siddique · Principal Investigator

Littleton Adventist Hospital

Littleton, Colorado, 80122

Suspended

Longmont United Hospital

Longmont, Colorado, 80501

Recruiting
Shahzad Siddique · Principal Investigator

Parker Adventist Hospital

Parker, Colorado, 80138

Suspended

Saint Mary Corwin Medical Center

Pueblo, Colorado, 81004

Recruiting
Shahzad Siddique · Principal Investigator

Smilow Cancer Hospital-Derby Care Center

Derby, Connecticut, 06418

Recruiting
Site Public Contact · Contact
Elan Gorshein · Principal Investigator

Smilow Cancer Hospital Care Center-Fairfield

Fairfield, Connecticut, 06824

Recruiting
Site Public Contact · Contact
Elan Gorshein · Principal Investigator

Smilow Cancer Hospital Care Center at Glastonbury

Glastonbury, Connecticut, 06033

Recruiting
Site Public Contact · Contact
Elan Gorshein · Principal Investigator

Smilow Cancer Hospital Care Center at Greenwich

Greenwich, Connecticut, 06830

Recruiting
Site Public Contact · Contact
Elan Gorshein · Principal Investigator

Smilow Cancer Hospital Care Center - Guilford

Guilford, Connecticut, 06437

Recruiting
Site Public Contact · Contact
Elan Gorshein · Principal Investigator

Smilow Cancer Hospital Care Center at Saint Francis

Hartford, Connecticut, 06105

Recruiting
Site Public Contact · Contact
Elan Gorshein · Principal Investigator

Smilow Cancer Center/Yale-New Haven Hospital

New Haven, Connecticut, 06510

Recruiting
Site Public Contact · Contact
Elan Gorshein · Principal Investigator

Yale University

New Haven, Connecticut, 06520

Recruiting
Site Public Contact · Contact
Elan Gorshein · Principal Investigator

Yale-New Haven Hospital North Haven Medical Center

North Haven, Connecticut, 06473

Recruiting
Site Public Contact · Contact
Elan Gorshein · Principal Investigator

Smilow Cancer Hospital Care Center at Long Ridge

Stamford, Connecticut, 06902

Recruiting
Site Public Contact · Contact
Elan Gorshein · Principal Investigator

Smilow Cancer Hospital-Torrington Care Center

Torrington, Connecticut, 06790

Recruiting
Site Public Contact · Contact
Elan Gorshein · Principal Investigator

Smilow Cancer Hospital Care Center-Trumbull

Trumbull, Connecticut, 06611

Recruiting
Site Public Contact · Contact
Elan Gorshein · Principal Investigator

Smilow Cancer Hospital-Waterbury Care Center

Waterbury, Connecticut, 06708

Recruiting
Site Public Contact · Contact
Elan Gorshein · Principal Investigator

Smilow Cancer Hospital Care Center - Waterford

Waterford, Connecticut, 06385

Recruiting
Site Public Contact · Contact
Elan Gorshein · Principal Investigator

Holy Cross Hospital

Fort Lauderdale, Florida, 33308

Recruiting
Site Public Contact · Contact
Elie G. Dib · Principal Investigator

Mayo Clinic in Florida

Jacksonville, Florida, 32224-9980

Recruiting
Site Public Contact · Contact
Sikander Ailawadhi · Principal Investigator

Jupiter Medical Center

Jupiter, Florida, 33458

Recruiting
Site Public Contact · Contact
Ryan H. Devine · Principal Investigator

Saint Luke's Cancer Institute - Boise

Boise, Idaho, 83712

Recruiting
Site Public Contact · Contact
Charles W. Drescher · Principal Investigator

Saint Luke's Cancer Institute - Fruitland

Fruitland, Idaho, 83619

Recruiting
Site Public Contact · Contact
Charles W. Drescher · Principal Investigator

Saint Luke's Cancer Institute - Meridian

Meridian, Idaho, 83642

Recruiting
Site Public Contact · Contact
Charles W. Drescher · Principal Investigator

Saint Luke's Cancer Institute - Nampa

Nampa, Idaho, 83686

Recruiting
Site Public Contact · Contact
Charles W. Drescher · Principal Investigator

Saint Luke's Cancer Institute - Twin Falls

Twin Falls, Idaho, 83301

Recruiting
Site Public Contact · Contact
Charles W. Drescher · Principal Investigator

Saint Anthony's Health

Alton, Illinois, 62002

Recruiting
Site Public Contact · Contact
Jay W. Carlson · Principal Investigator

Rush - Copley Medical Center

Aurora, Illinois, 60504

Recruiting
Site Public Contact · Contact
Maria T. Grosse-Perdekamp · Principal Investigator

Saint Joseph Medical Center

Bloomington, Illinois, 61701

Recruiting
Site Public Contact · Contact
Bryan A. Faller · Principal Investigator

Illinois CancerCare-Bloomington

Bloomington, Illinois, 61704

Recruiting
Site Public Contact · Contact
Bryan A. Faller · Principal Investigator

Loyola Center for Health at Burr Ridge

Burr Ridge, Illinois, 60527

Recruiting
Site Public Contact · Contact
Patrick A. Hagen · Principal Investigator

Illinois CancerCare-Canton

Canton, Illinois, 61520

Recruiting
Site Public Contact · Contact
Bryan A. Faller · Principal Investigator

Memorial Hospital of Carbondale

Carbondale, Illinois, 62902

Recruiting
Site Public Contact · Contact
Bryan A. Faller · Principal Investigator

SIH Cancer Institute

Carterville, Illinois, 62918

Recruiting
Site Public Contact · Contact
Bryan A. Faller · Principal Investigator

Illinois CancerCare-Carthage

Carthage, Illinois, 62321

Recruiting
Site Public Contact · Contact
Bryan A. Faller · Principal Investigator

Centralia Oncology Clinic

Centralia, Illinois, 62801

Recruiting
Site Public Contact · Contact
Bryan A. Faller · Principal Investigator

Saint Mary's Hospital

Centralia, Illinois, 62801

Recruiting
Site Public Contact · Contact
Jay W. Carlson · Principal Investigator

Carle at The Riverfront

Danville, Illinois, 61832

Recruiting
Site Public Contact · Contact
Maria T. Grosse-Perdekamp · Principal Investigator

Cancer Care Specialists of Illinois - Decatur

Decatur, Illinois, 62526

Recruiting
Site Public Contact · Contact
Bryan A. Faller · Principal Investigator

Decatur Memorial Hospital

Decatur, Illinois, 62526

Recruiting
Site Public Contact · Contact
Bryan A. Faller · Principal Investigator

Illinois CancerCare-Dixon

Dixon, Illinois, 61021

Recruiting
Site Public Contact · Contact
Bryan A. Faller · Principal Investigator

Carle Physician Group-Effingham

Effingham, Illinois, 62401

Recruiting
Site Public Contact · Contact
Maria T. Grosse-Perdekamp · Principal Investigator

Crossroads Cancer Center

Effingham, Illinois, 62401

Recruiting
Site Public Contact · Contact
Bryan A. Faller · Principal Investigator

Illinois CancerCare-Eureka

Eureka, Illinois, 61530

Recruiting
Site Public Contact · Contact
Bryan A. Faller · Principal Investigator

Illinois CancerCare-Galesburg

Galesburg, Illinois, 61401

Recruiting
Site Public Contact · Contact
Bryan A. Faller · Principal Investigator

Western Illinois Cancer Treatment Center

Galesburg, Illinois, 61401

Recruiting
Site Public Contact · Contact
Bryan A. Faller · Principal Investigator

Edward Hines Jr VA Hospital

Hines, Illinois, 60141

Recruiting
Site Public Contact · Contact
Kathleen W. Phelan · Principal Investigator

Loyola Medicine Homer Glen

Homer Glen, Illinois, 60491

Recruiting
Site Public Contact · Contact
Patrick A. Hagen · Principal Investigator

Illinois CancerCare-Kewanee Clinic

Kewanee, Illinois, 61443

Recruiting
Site Public Contact · Contact
Bryan A. Faller · Principal Investigator

Illinois CancerCare-Macomb

Macomb, Illinois, 61455

Recruiting
Site Public Contact · Contact
Bryan A. Faller · Principal Investigator

Carle Physician Group-Mattoon/Charleston

Mattoon, Illinois, 61938

Recruiting
Site Public Contact · Contact
Maria T. Grosse-Perdekamp · Principal Investigator

Loyola University Medical Center

Maywood, Illinois, 60153

Recruiting
Site Public Contact · Contact
Patrick A. Hagen · Principal Investigator

Marjorie Weinberg Cancer Center at Loyola-Gottlieb

Melrose Park, Illinois, 60160

Recruiting
Site Public Contact · Contact
Patrick A. Hagen · Principal Investigator

Good Samaritan Regional Health Center

Mount Vernon, Illinois, 62864

Recruiting
Site Public Contact · Contact
Jay W. Carlson · Principal Investigator

Cancer Care Center of O'Fallon

O'Fallon, Illinois, 62269

Recruiting
Site Public Contact · Contact
Bryan A. Faller · Principal Investigator

HSHS Saint Elizabeth's Hospital

O'Fallon, Illinois, 62269

Recruiting
Site Public Contact · Contact
Bryan A. Faller · Principal Investigator

Illinois CancerCare-Ottawa Clinic

Ottawa, Illinois, 61350

Recruiting
Site Public Contact · Contact
Bryan A. Faller · Principal Investigator

Illinois CancerCare-Pekin

Pekin, Illinois, 61554

Recruiting
Site Public Contact · Contact
Bryan A. Faller · Principal Investigator

Illinois CancerCare-Peoria

Peoria, Illinois, 61615

Recruiting
Site Public Contact · Contact
Bryan A. Faller · Principal Investigator

Methodist Medical Center of Illinois

Peoria, Illinois, 61636

Recruiting
Site Public Contact · Contact
Bryan A. Faller · Principal Investigator

Illinois CancerCare-Peru

Peru, Illinois, 61354

Recruiting
Site Public Contact · Contact
Bryan A. Faller · Principal Investigator

Valley Radiation Oncology

Peru, Illinois, 61354

Recruiting
Site Public Contact · Contact
Bryan A. Faller · Principal Investigator

Illinois CancerCare-Princeton

Princeton, Illinois, 61356

Recruiting
Site Public Contact · Contact
Bryan A. Faller · Principal Investigator

Southern Illinois University School of Medicine

Springfield, Illinois, 62702

Recruiting
Site Public Contact · Contact
Bryan A. Faller · Principal Investigator

Springfield Clinic

Springfield, Illinois, 62702

Recruiting
Site Public Contact · Contact
Bryan A. Faller · Principal Investigator

Memorial Medical Center

Springfield, Illinois, 62781

Recruiting
Site Public Contact · Contact
Bryan A. Faller · Principal Investigator

Carle Cancer Center

Urbana, Illinois, 61801

Recruiting
Site Public Contact · Contact
Maria T. Grosse-Perdekamp · Principal Investigator

The Carle Foundation Hospital

Urbana, Illinois, 61801

Recruiting
Site Public Contact · Contact
Maria T. Grosse-Perdekamp · Principal Investigator

Illinois CancerCare - Washington

Washington, Illinois, 61571

Recruiting
Site Public Contact · Contact
Bryan A. Faller · Principal Investigator

Rush-Copley Healthcare Center

Yorkville, Illinois, 60560

Recruiting
Site Public Contact · Contact
Maria T. Grosse-Perdekamp · Principal Investigator

IU Health North Hospital

Carmel, Indiana, 46032

Recruiting
Site Public Contact · Contact
Attaya Suvannasankha · Principal Investigator

Northwest Cancer Center - Main Campus

Crown Point, Indiana, 46307

Recruiting
Site Public Contact · Contact
Maria T. Grosse-Perdekamp · Principal Investigator

Northwest Oncology LLC

Dyer, Indiana, 46311

Recruiting
Site Public Contact · Contact
Maria T. Grosse-Perdekamp · Principal Investigator

Northwest Cancer Center - Hobart

Hobart, Indiana, 46342

Recruiting
Site Public Contact · Contact
Maria T. Grosse-Perdekamp · Principal Investigator

Saint Mary Medical Center

Hobart, Indiana, 46342

Recruiting
Site Public Contact · Contact
Maria T. Grosse-Perdekamp · Principal Investigator

Indiana University/Melvin and Bren Simon Cancer Center

Indianapolis, Indiana, 46202

Recruiting
Site Public Contact · Contact
Attaya Suvannasankha · Principal Investigator

Saint Catherine Hospital

Indianapolis, Indiana, 46312

Recruiting
Site Public Contact · Contact
Maria T. Grosse-Perdekamp · Principal Investigator

The Community Hospital

Munster, Indiana, 46321

Recruiting
Site Public Contact · Contact
Maria T. Grosse-Perdekamp · Principal Investigator

Women's Diagnostic Center - Munster

Munster, Indiana, 46321

Recruiting
Site Public Contact · Contact
Maria T. Grosse-Perdekamp · Principal Investigator

Reid Health

Richmond, Indiana, 47374

Recruiting
Site Public Contact · Contact
Howard M. Gross · Principal Investigator

Northwest Cancer Center - Valparaiso

Valparaiso, Indiana, 46383

Recruiting
Site Public Contact · Contact
Maria T. Grosse-Perdekamp · Principal Investigator

Mission Cancer and Blood - Ankeny

Ankeny, Iowa, 50023

Recruiting
Site Public Contact · Contact
Richard L. Deming · Principal Investigator

University of Iowa Healthcare Cancer Services Quad Cities

Bettendorf, Iowa, 52722

Recruiting
Site Public Contact · Contact
Hira Shaikh · Principal Investigator

Physicians' Clinic of Iowa PC

Cedar Rapids, Iowa, 52402

Recruiting
Site Public Contact · Contact
Bharat Jenigiri · Principal Investigator

Medical Oncology and Hematology Associates-West Des Moines

Clive, Iowa, 50325

Recruiting
Site Public Contact · Contact
Richard L. Deming · Principal Investigator

Mercy Cancer Center-West Lakes

Clive, Iowa, 50325

Recruiting
Site Public Contact · Contact
Richard L. Deming · Principal Investigator

Alegent Health Mercy Hospital

Council Bluffs, Iowa, 51503

Suspended

Greater Regional Medical Center

Creston, Iowa, 50801

Recruiting
Site Public Contact · Contact
Richard L. Deming · Principal Investigator

Mercy Medical Center - Des Moines

Des Moines, Iowa, 50314

Recruiting
Site Public Contact · Contact
Richard L. Deming · Principal Investigator

Mission Cancer and Blood - Laurel

Des Moines, Iowa, 50314

Recruiting
Site Public Contact · Contact
Richard L. Deming · Principal Investigator

University of Iowa/Holden Comprehensive Cancer Center

Iowa City, Iowa, 52242

Recruiting
Site Public Contact · Contact
Hira Shaikh · Principal Investigator

Mercy Medical Center-West Lakes

West Des Moines, Iowa, 50266

Recruiting
Site Public Contact · Contact
Richard L. Deming · Principal Investigator

Central Care Cancer Center - Garden City

Garden City, Kansas, 67846

Recruiting
Site Public Contact · Contact
Jay W. Carlson · Principal Investigator

Central Care Cancer Center - Great Bend

Great Bend, Kansas, 67530

Recruiting
Site Public Contact · Contact
Jay W. Carlson · Principal Investigator

Flaget Memorial Hospital

Bardstown, Kentucky, 40004

Recruiting
Shahzad Siddique · Principal Investigator

Commonwealth Cancer Center-Corbin

Corbin, Kentucky, 40701

Recruiting
Shahzad Siddique · Principal Investigator

Saint Joseph Hospital

Lexington, Kentucky, 40504

Recruiting
Shahzad Siddique · Principal Investigator

Saint Joseph Radiation Oncology Resource Center

Lexington, Kentucky, 40504

Recruiting
Shahzad Siddique · Principal Investigator

Saint Joseph Hospital East

Lexington, Kentucky, 40509

Recruiting
Shahzad Siddique · Principal Investigator

Saint Joseph London

London, Kentucky, 40741

Recruiting
Shahzad Siddique · Principal Investigator

Saint Joseph Mount Sterling

Mount Sterling, Kentucky, 40353

Recruiting
Shahzad Siddique · Principal Investigator

Greater Baltimore Medical Center

Baltimore, Maryland, 21204

Recruiting
Site Public Contact · Contact
Ari H. Elman · Principal Investigator

Saint Joseph Mercy Hospital

Ann Arbor, Michigan, 48106

Recruiting
Elie G. Dib · Principal Investigator

Bronson Battle Creek

Battle Creek, Michigan, 49017

Recruiting
Site Public Contact · Contact
Kathleen J. Yost · Principal Investigator

Saint Joseph Mercy Brighton

Brighton, Michigan, 48114

Recruiting
Elie G. Dib · Principal Investigator

Trinity Health IHA Medical Group Hematology Oncology - Brighton

Brighton, Michigan, 48114

Recruiting
Elie G. Dib · Principal Investigator

Saint Joseph Mercy Canton

Canton, Michigan, 48188

Recruiting
Elie G. Dib · Principal Investigator

Trinity Health IHA Medical Group Hematology Oncology - Canton

Canton, Michigan, 48188

Recruiting
Elie G. Dib · Principal Investigator

Caro Cancer Center

Caro, Michigan, 48723

Recruiting
Site Public Contact · Contact
Elie G. Dib · Principal Investigator

Saint Joseph Mercy Chelsea

Chelsea, Michigan, 48118

Recruiting
Elie G. Dib · Principal Investigator

Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital

Chelsea, Michigan, 48118

Recruiting
Elie G. Dib · Principal Investigator

Hematology Oncology Consultants-Clarkston

Clarkston, Michigan, 48346

Recruiting
Elie G. Dib · Principal Investigator

Newland Medical Associates-Clarkston

Clarkston, Michigan, 48346

Recruiting
Elie G. Dib · Principal Investigator

Ascension Saint John Hospital

Detroit, Michigan, 48236

Recruiting
Site Public Contact · Contact
Elie G. Dib · Principal Investigator

Great Lakes Cancer Management Specialists-Doctors Park

East China, Michigan, 48054

Recruiting
Site Public Contact · Contact
Elie G. Dib · Principal Investigator

Genesee Cancer and Blood Disease Treatment Center

Flint, Michigan, 48503

Recruiting
Site Public Contact · Contact
Elie G. Dib · Principal Investigator

Genesee Hematology Oncology PC

Flint, Michigan, 48503

Recruiting
Site Public Contact · Contact
Elie G. Dib · Principal Investigator

Genesys Hurley Cancer Institute

Flint, Michigan, 48503

Recruiting
Site Public Contact · Contact
Elie G. Dib · Principal Investigator

Hurley Medical Center

Flint, Michigan, 48503

Recruiting
Site Public Contact · Contact
Elie G. Dib · Principal Investigator

Helen DeVos Children's Hospital at Spectrum Health

Grand Rapids, Michigan, 49503

Recruiting
Site Public Contact · Contact
Kathleen J. Yost · Principal Investigator

Spectrum Health at Butterworth Campus

Grand Rapids, Michigan, 49503

Recruiting
Site Public Contact · Contact
Kathleen J. Yost · Principal Investigator

Trinity Health Grand Rapids Hospital

Grand Rapids, Michigan, 49503

Recruiting
Site Public Contact · Contact
Kathleen J. Yost · Principal Investigator

Academic Hematology Oncology Specialists

Grosse Pointe Woods, Michigan, 48236

Recruiting
Site Public Contact · Contact
Elie G. Dib · Principal Investigator

Great Lakes Cancer Management Specialists-Van Elslander Cancer Center

Grosse Pointe Woods, Michigan, 48236

Recruiting
Site Public Contact · Contact
Elie G. Dib · Principal Investigator

Bronson Methodist Hospital

Kalamazoo, Michigan, 49007

Recruiting
Site Public Contact · Contact
Kathleen J. Yost · Principal Investigator

West Michigan Cancer Center

Kalamazoo, Michigan, 49007

Recruiting
Site Public Contact · Contact
Kathleen J. Yost · Principal Investigator

Ascension Borgess Cancer Center

Kalamazoo, Michigan, 49009

Recruiting
Site Public Contact · Contact
Kathleen J. Yost · Principal Investigator

Borgess Medical Center

Kalamazoo, Michigan, 49048

Recruiting
Site Public Contact · Contact
Kathleen J. Yost · Principal Investigator

University of Michigan Health - Sparrow Lansing

Lansing, Michigan, 48912

Recruiting
Site Public Contact · Contact
Elie G. Dib · Principal Investigator

Trinity Health Saint Mary Mercy Livonia Hospital

Livonia, Michigan, 48154

Recruiting
Elie G. Dib · Principal Investigator

Great Lakes Cancer Management Specialists-Macomb Medical Campus

Macomb, Michigan, 48044

Recruiting
Site Public Contact · Contact
Elie G. Dib · Principal Investigator

Saint Mary's Oncology/Hematology Associates of Marlette

Marlette, Michigan, 48453

Recruiting
Site Public Contact · Contact
Elie G. Dib · Principal Investigator

Trinity Health Muskegon Hospital

Muskegon, Michigan, 49444

Recruiting
Site Public Contact · Contact
Kathleen J. Yost · Principal Investigator

Corewell Health Lakeland Hospitals - Niles Hospital

Niles, Michigan, 49120

Recruiting
Site Public Contact · Contact
Kathleen J. Yost · Principal Investigator

Cancer and Hematology Centers of Western Michigan - Norton Shores

Norton Shores, Michigan, 49444

Recruiting
Site Public Contact · Contact
Kathleen J. Yost · Principal Investigator

21st Century Oncology-Pontiac

Pontiac, Michigan, 48341

Recruiting
Site Public Contact · Contact
Elie G. Dib · Principal Investigator

Hope Cancer Center

Pontiac, Michigan, 48341

Recruiting
Elie G. Dib · Principal Investigator

Newland Medical Associates-Pontiac

Pontiac, Michigan, 48341

Recruiting
Elie G. Dib · Principal Investigator

Saint Joseph Mercy Oakland

Pontiac, Michigan, 48341

Recruiting
Elie G. Dib · Principal Investigator

Corewell Health Reed City Hospital

Reed City, Michigan, 49677

Recruiting
Site Public Contact · Contact
Kathleen J. Yost · Principal Investigator

Ascension Saint Mary's Hospital

Saginaw, Michigan, 48601

Recruiting
Site Public Contact · Contact
Elie G. Dib · Principal Investigator

Oncology Hematology Associates of Saginaw Valley PC

Saginaw, Michigan, 48604

Recruiting
Site Public Contact · Contact
Elie G. Dib · Principal Investigator

Corewell Health Lakeland Hospitals - Marie Yeager Cancer Center

Saint Joseph, Michigan, 49085

Recruiting
Site Public Contact · Contact
Kathleen J. Yost · Principal Investigator

Lakeland Medical Center Saint Joseph

Saint Joseph, Michigan, 49085

Recruiting
Site Public Contact · Contact
Kathleen J. Yost · Principal Investigator

Bhadresh Nayak MD PC-Sterling Heights

Sterling Heights, Michigan, 48312

Recruiting
Site Public Contact · Contact
Elie G. Dib · Principal Investigator

Ascension Saint Joseph Hospital

Tawas City, Michigan, 48764

Recruiting
Site Public Contact · Contact
Elie G. Dib · Principal Investigator

Munson Medical Center

Traverse City, Michigan, 49684

Recruiting
Site Public Contact · Contact
Kathleen J. Yost · Principal Investigator

Advanced Breast Care Center PLLC

Warren, Michigan, 48088

Recruiting
Site Public Contact · Contact
Elie G. Dib · Principal Investigator

Great Lakes Cancer Management Specialists-Macomb Professional Building

Warren, Michigan, 48093

Recruiting
Site Public Contact · Contact
Elie G. Dib · Principal Investigator

Macomb Hematology Oncology PC

Warren, Michigan, 48093

Recruiting
Site Public Contact · Contact
Elie G. Dib · Principal Investigator

Michigan Breast Specialists-Warren

Warren, Michigan, 48093

Recruiting
Site Public Contact · Contact
Elie G. Dib · Principal Investigator

Saint John Macomb-Oakland Hospital

Warren, Michigan, 48093

Recruiting
Site Public Contact · Contact
Elie G. Dib · Principal Investigator

Saint Mary's Oncology/Hematology Associates of West Branch

West Branch, Michigan, 48661

Recruiting
Site Public Contact · Contact
Elie G. Dib · Principal Investigator

University of Michigan Health - West

Wyoming, Michigan, 49519

Recruiting
Site Public Contact · Contact
Kathleen J. Yost · Principal Investigator

Huron Gastroenterology PC

Ypsilanti, Michigan, 48106

Recruiting
Elie G. Dib · Principal Investigator

Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus

Ypsilanti, Michigan, 48197

Recruiting
Elie G. Dib · Principal Investigator

Riverwood Healthcare Center

Aitkin, Minnesota, 56431

Recruiting
Site Public Contact · Contact
Bret E. Friday · Principal Investigator

Essentia Health - Baxter Clinic

Baxter, Minnesota, 56425

Recruiting
Site Public Contact · Contact
Bret E. Friday · Principal Investigator

Sanford Joe Lueken Cancer Center

Bemidji, Minnesota, 56601

Recruiting
Daniel Almquist · Principal Investigator

Essentia Health Saint Joseph's Medical Center

Brainerd, Minnesota, 56401

Recruiting
Site Public Contact · Contact
Bret E. Friday · Principal Investigator

Minnesota Oncology - Burnsville

Burnsville, Minnesota, 55337

Recruiting
Site Public Contact · Contact
David M. King · Principal Investigator

Cambridge Medical Center

Cambridge, Minnesota, 55008

Recruiting
Site Public Contact · Contact
David M. King · Principal Investigator

Mercy Hospital

Coon Rapids, Minnesota, 55433

Recruiting
Site Public Contact · Contact
David M. King · Principal Investigator

Essentia Health - Deer River Clinic

Deer River, Minnesota, 56636

Recruiting
Site Public Contact · Contact
Bret E. Friday · Principal Investigator

Essentia Health Saint Mary's - Detroit Lakes Clinic

Detroit Lakes, Minnesota, 56501

Recruiting
Site Public Contact · Contact
Bret E. Friday · Principal Investigator

Essentia Health Cancer Center

Duluth, Minnesota, 55805

Recruiting
Site Public Contact · Contact
Bret E. Friday · Principal Investigator

Essentia Health Saint Mary's Medical Center

Duluth, Minnesota, 55805

Recruiting
Site Public Contact · Contact
Bret E. Friday · Principal Investigator

Miller-Dwan Hospital

Duluth, Minnesota, 55805

Recruiting
Site Public Contact · Contact
Bret E. Friday · Principal Investigator

Fairview Southdale Hospital

Edina, Minnesota, 55435

Recruiting
Site Public Contact · Contact
David M. King · Principal Investigator

Essentia Health - Ely Clinic

Ely, Minnesota, 55731

Recruiting
Site Public Contact · Contact
Bret E. Friday · Principal Investigator

Essentia Health - Fosston

Fosston, Minnesota, 56542

Recruiting
Site Public Contact · Contact
Bret E. Friday · Principal Investigator

Unity Hospital

Fridley, Minnesota, 55432

Active Not Recruiting

Essentia Health Hibbing Clinic

Hibbing, Minnesota, 55746

Recruiting
Site Public Contact · Contact
Bret E. Friday · Principal Investigator

Essentia Health - International Falls Clinic

International Falls, Minnesota, 56649

Recruiting
Site Public Contact · Contact
Bret E. Friday · Principal Investigator

Fairview Clinics and Surgery Center Maple Grove

Maple Grove, Minnesota, 55369

Recruiting
Site Public Contact · Contact
David M. King · Principal Investigator

Minnesota Oncology Hematology PA-Maplewood

Maplewood, Minnesota, 55109

Recruiting
Site Public Contact · Contact
David M. King · Principal Investigator

Saint John's Hospital - Healtheast

Maplewood, Minnesota, 55109

Recruiting
Site Public Contact · Contact
David M. King · Principal Investigator

Abbott-Northwestern Hospital

Minneapolis, Minnesota, 55407

Recruiting
Site Public Contact · Contact
David M. King · Principal Investigator

Hennepin County Medical Center

Minneapolis, Minnesota, 55415

Recruiting
Site Public Contact · Contact
David M. King · Principal Investigator

Health Partners Inc

Minneapolis, Minnesota, 55454

Recruiting
Site Public Contact · Contact
David M. King · Principal Investigator

Monticello Cancer Center

Monticello, Minnesota, 55362

Recruiting
Site Public Contact · Contact
David M. King · Principal Investigator

Essentia Health - Moose Lake Clinic

Moose Lake, Minnesota, 55767

Recruiting
Site Public Contact · Contact
Bret E. Friday · Principal Investigator

New Ulm Medical Center

New Ulm, Minnesota, 56073

Recruiting
Site Public Contact · Contact
David M. King · Principal Investigator

Essentia Health - Park Rapids

Park Rapids, Minnesota, 56470

Recruiting
Site Public Contact · Contact
Bret E. Friday · Principal Investigator

Fairview Northland Medical Center

Princeton, Minnesota, 55371

Recruiting
Site Public Contact · Contact
David M. King · Principal Investigator

North Memorial Medical Health Center

Robbinsdale, Minnesota, 55422

Recruiting
Site Public Contact · Contact
David M. King · Principal Investigator

Mayo Clinic in Rochester

Rochester, Minnesota, 55905

Recruiting
Site Public Contact · Contact
Sikander Ailawadhi · Principal Investigator

Park Nicollet Clinic - Saint Louis Park

Saint Louis Park, Minnesota, 55416

Recruiting
Site Public Contact · Contact
David M. King · Principal Investigator

Regions Hospital

Saint Paul, Minnesota, 55101

Recruiting
Site Public Contact · Contact
David M. King · Principal Investigator

United Hospital

Saint Paul, Minnesota, 55102

Recruiting
Site Public Contact · Contact
David M. King · Principal Investigator

Essentia Health Sandstone

Sandstone, Minnesota, 55072

Recruiting
Site Public Contact · Contact
Bret E. Friday · Principal Investigator

Saint Francis Regional Medical Center

Shakopee, Minnesota, 55379

Recruiting
Site Public Contact · Contact
David M. King · Principal Investigator

Lakeview Hospital

Stillwater, Minnesota, 55082

Recruiting
Site Public Contact · Contact
David M. King · Principal Investigator

Sanford Thief River Falls Medical Center

Thief River Falls, Minnesota, 56701

Recruiting
Site Public Contact · Contact
Daniel Almquist · Principal Investigator

Essentia Health Virginia Clinic

Virginia, Minnesota, 55792

Recruiting
Site Public Contact · Contact
Bret E. Friday · Principal Investigator

Ridgeview Medical Center

Waconia, Minnesota, 55387

Recruiting
Site Public Contact · Contact
David M. King · Principal Investigator

Rice Memorial Hospital

Willmar, Minnesota, 56201

Recruiting
Site Public Contact · Contact
David M. King · Principal Investigator

Minnesota Oncology Hematology PA-Woodbury

Woodbury, Minnesota, 55125

Recruiting
Site Public Contact · Contact
David M. King · Principal Investigator

Sanford Cancer Center Worthington

Worthington, Minnesota, 56187

Recruiting
Site Public Contact · Contact
Daniel Almquist · Principal Investigator

Fairview Lakes Medical Center

Wyoming, Minnesota, 55092

Recruiting
Site Public Contact · Contact
David M. King · Principal Investigator

Saint Louis Cancer and Breast Institute-Ballwin

Ballwin, Missouri, 63011

Recruiting
Site Public Contact · Contact
Jay W. Carlson · Principal Investigator

Central Care Cancer Center - Bolivar

Bolivar, Missouri, 65613

Recruiting
Site Public Contact · Contact
Jay W. Carlson · Principal Investigator

Cox Cancer Center Branson

Branson, Missouri, 65616

Recruiting
Site Public Contact · Contact
Jay W. Carlson · Principal Investigator

Saint Francis Medical Center

Cape Girardeau, Missouri, 63703

Recruiting
Site Public Contact · Contact
Bryan A. Faller · Principal Investigator

Southeast Cancer Center

Cape Girardeau, Missouri, 63703

Recruiting
Site Public Contact · Contact
Bryan A. Faller · Principal Investigator

Parkland Health Center - Farmington

Farmington, Missouri, 63640

Recruiting
Site Public Contact · Contact
Bryan A. Faller · Principal Investigator

Capital Region Southwest Campus

Jefferson City, Missouri, 65109

Recruiting
Site Public Contact · Contact
Bryan A. Faller · Principal Investigator

Freeman Health System

Joplin, Missouri, 64804

Recruiting
Site Public Contact · Contact
Jay W. Carlson · Principal Investigator

Mercy Hospital Joplin

Joplin, Missouri, 64804

Recruiting
Site Public Contact · Contact
Jay W. Carlson · Principal Investigator

Research Medical Center

Kansas City, Missouri, 64132

Recruiting
Site Public Contact · Contact
Suman Kambhampati · Principal Investigator

Lake Regional Hospital

Osage Beach, Missouri, 65065

Recruiting
Site Public Contact · Contact
Jay W. Carlson · Principal Investigator

Delbert Day Cancer Institute at PCRMC

Rolla, Missouri, 65401

Recruiting
Site Public Contact · Contact
Jay W. Carlson · Principal Investigator

Mercy Clinic-Rolla-Cancer and Hematology

Rolla, Missouri, 65401

Recruiting
Site Public Contact · Contact
Jay W. Carlson · Principal Investigator

Heartland Regional Medical Center

Saint Joseph, Missouri, 64506

Recruiting
Site Public Contact · Contact
Jay W. Carlson · Principal Investigator

Sainte Genevieve County Memorial Hospital

Sainte Genevieve, Missouri, 63670

Recruiting
Site Public Contact · Contact
Bryan A. Faller · Principal Investigator

Mercy Hospital Springfield

Springfield, Missouri, 65804

Recruiting
Site Public Contact · Contact
Jay W. Carlson · Principal Investigator

CoxHealth South Hospital

Springfield, Missouri, 65807

Recruiting
Site Public Contact · Contact
Jay W. Carlson · Principal Investigator

Saint Louis Cancer and Breast Institute-South City

St Louis, Missouri, 63109

Recruiting
Site Public Contact · Contact
Jay W. Carlson · Principal Investigator

Mercy Hospital South

St Louis, Missouri, 63128

Recruiting
Site Public Contact · Contact
Jay W. Carlson · Principal Investigator

Missouri Baptist Medical Center

St Louis, Missouri, 63131

Recruiting
Site Public Contact · Contact
Bryan A. Faller · Principal Investigator

Mercy Hospital Saint Louis

St Louis, Missouri, 63141

Recruiting
Site Public Contact · Contact
Jay W. Carlson · Principal Investigator

Missouri Baptist Sullivan Hospital

Sullivan, Missouri, 63080

Recruiting
Site Public Contact · Contact
Bryan A. Faller · Principal Investigator

BJC Outpatient Center at Sunset Hills

Sunset Hills, Missouri, 63127

Recruiting
Site Public Contact · Contact
Bryan A. Faller · Principal Investigator

Mercy Hospital Washington

Washington, Missouri, 63090

Recruiting
Site Public Contact · Contact
Jay W. Carlson · Principal Investigator

Saint Patrick Hospital - Community Hospital

Missoula, Montana, 59802

Recruiting
Site Public Contact · Contact
Charles W. Drescher · Principal Investigator

CHI Health Good Samaritan

Kearney, Nebraska, 68847

Recruiting
Shahzad Siddique · Principal Investigator

Saint Elizabeth Regional Medical Center

Lincoln, Nebraska, 68510

Suspended

Alegent Health Immanuel Medical Center

Omaha, Nebraska, 68122

Recruiting
Shahzad Siddique · Principal Investigator

Alegent Health Bergan Mercy Medical Center

Omaha, Nebraska, 68124

Recruiting
Shahzad Siddique · Principal Investigator

Alegent Health Lakeside Hospital

Omaha, Nebraska, 68130

Recruiting
Shahzad Siddique · Principal Investigator

Creighton University Medical Center

Omaha, Nebraska, 68131

Recruiting
Shahzad Siddique · Principal Investigator

Midlands Community Hospital

Papillion, Nebraska, 68046

Suspended

Exeter Hospital

Exeter, New Hampshire, 03833

Recruiting
Site Public Contact · Contact
Cocav A. Rauwerdink · Principal Investigator

Lovelace Medical Center-Saint Joseph Square

Albuquerque, New Mexico, 87102

Recruiting
Site Public Contact · Contact
Shashank Cingam · Principal Investigator

University of New Mexico Cancer Center

Albuquerque, New Mexico, 87102

Recruiting
Shashank Cingam · Principal Investigator

Presbyterian Kaseman Hospital

Albuquerque, New Mexico, 87110

Recruiting
Site Public Contact · Contact
Shashank Cingam · Principal Investigator

Presbyterian Rust Medical Center/Jorgensen Cancer Center

Rio Rancho, New Mexico, 87124

Recruiting
Site Public Contact · Contact
Shashank Cingam · Principal Investigator

NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center

New York, New York, 10032

Recruiting
Divaya Bhutani · Principal Investigator

University of Rochester

Rochester, New York, 14642

Recruiting
Site Public Contact · Contact
Paul M. Barr · Principal Investigator

Sanford Bismarck Medical Center

Bismarck, North Dakota, 58501

Recruiting
Daniel Almquist · Principal Investigator

Essentia Health Cancer Center-South University Clinic

Fargo, North Dakota, 58103

Recruiting
Site Public Contact · Contact
Bret E. Friday · Principal Investigator

Sanford South University Medical Center

Fargo, North Dakota, 58103

Recruiting
Site Public Contact · Contact
Daniel Almquist · Principal Investigator

Southpointe-Sanford Medical Center Fargo

Fargo, North Dakota, 58103

Recruiting
Site Public Contact · Contact
Daniel Almquist · Principal Investigator

Sanford Medical Center Fargo

Fargo, North Dakota, 58104

Recruiting
Site Public Contact · Contact
Daniel Almquist · Principal Investigator

Sanford Broadway Medical Center

Fargo, North Dakota, 58122

Recruiting
Daniel Almquist · Principal Investigator

Sanford Roger Maris Cancer Center

Fargo, North Dakota, 58122

Recruiting
Daniel Almquist · Principal Investigator

Essentia Health - Jamestown Clinic

Jamestown, North Dakota, 58401

Recruiting
Site Public Contact · Contact
Bret E. Friday · Principal Investigator

Indu and Raj Soin Medical Center

Beavercreek, Ohio, 45431

Recruiting
Site Public Contact · Contact
Howard M. Gross · Principal Investigator

Saint Elizabeth Boardman Hospital

Boardman, Ohio, 44512

Recruiting
Site Public Contact · Contact
Howard M. Gross · Principal Investigator

Dayton Physicians LLC-Miami Valley South

Centerville, Ohio, 45459

Recruiting
Site Public Contact · Contact
Howard M. Gross · Principal Investigator

Good Samaritan Hospital - Cincinnati

Cincinnati, Ohio, 45220

Recruiting
Shahzad Siddique · Principal Investigator

Oncology Hematology Care Inc-Kenwood

Cincinnati, Ohio, 45236

Recruiting
Site Public Contact · Contact
Howard M. Gross · Principal Investigator

Bethesda North Hospital

Cincinnati, Ohio, 45242

Recruiting
Shahzad Siddique · Principal Investigator

TriHealth Cancer Institute-Westside

Cincinnati, Ohio, 45247

Recruiting
Shahzad Siddique · Principal Investigator

TriHealth Cancer Institute-Anderson

Cincinnati, Ohio, 45255

Recruiting
Shahzad Siddique · Principal Investigator

Dayton Physician LLC-Miami Valley Hospital North

Dayton, Ohio, 45415

Recruiting
Site Public Contact · Contact
Howard M. Gross · Principal Investigator

Armes Family Cancer Center

Findlay, Ohio, 45840

Recruiting
Site Public Contact · Contact
Howard M. Gross · Principal Investigator

Blanchard Valley Hospital

Findlay, Ohio, 45840

Recruiting
Site Public Contact · Contact
Howard M. Gross · Principal Investigator

Orion Cancer Care

Findlay, Ohio, 45840

Recruiting
Site Public Contact · Contact
Howard M. Gross · Principal Investigator

Dayton Physicians LLC-Atrium

Franklin, Ohio, 45005

Recruiting
Site Public Contact · Contact
Howard M. Gross · Principal Investigator

Dayton Physicians LLC-Wayne

Greenville, Ohio, 45331

Recruiting
Site Public Contact · Contact
Howard M. Gross · Principal Investigator

Wayne Hospital

Greenville, Ohio, 45331

Recruiting
Site Public Contact · Contact
Howard M. Gross · Principal Investigator

Greater Dayton Cancer Center

Kettering, Ohio, 45409

Recruiting
Site Public Contact · Contact
Howard M. Gross · Principal Investigator

Kettering Medical Center

Kettering, Ohio, 45429

Recruiting
Site Public Contact · Contact
Howard M. Gross · Principal Investigator

Dayton Physicians LLC - Troy

Troy, Ohio, 45373

Recruiting
Site Public Contact · Contact
Howard M. Gross · Principal Investigator

Saint Joseph Warren Hospital

Warren, Ohio, 44484

Recruiting
Site Public Contact · Contact
Howard M. Gross · Principal Investigator

Saint Elizabeth Youngstown Hospital

Youngstown, Ohio, 44501

Recruiting
Site Public Contact · Contact
Howard M. Gross · Principal Investigator

University of Oklahoma Health Sciences Center

Oklahoma City, Oklahoma, 73104

Not Yet Recruiting
Site Public Contact · Contact
Manu Pandey · Principal Investigator

Mercy Hospital Oklahoma City

Oklahoma City, Oklahoma, 73120

Recruiting
Site Public Contact · Contact
Jay W. Carlson · Principal Investigator

Saint Charles Health System

Bend, Oregon, 97701

Recruiting
Site Public Contact · Contact
Charles W. Drescher · Principal Investigator

Clackamas Radiation Oncology Center

Clackamas, Oregon, 97015

Recruiting
Site Public Contact · Contact
Charles W. Drescher · Principal Investigator

Providence Cancer Institute Clackamas Clinic

Clackamas, Oregon, 97015

Recruiting
Site Public Contact · Contact
Charles W. Drescher · Principal Investigator

Bay Area Hospital

Coos Bay, Oregon, 97420

Recruiting
Site Public Contact · Contact
Charles W. Drescher · Principal Investigator

Rogue Valley Medical Center

Medford, Oregon, 97504

Recruiting
Site Public Contact · Contact
Alison D. Savage · Principal Investigator

Providence Newberg Medical Center

Newberg, Oregon, 97132

Recruiting
Site Public Contact · Contact
Charles W. Drescher · Principal Investigator

Providence Willamette Falls Medical Center

Oregon City, Oregon, 97045

Recruiting
Site Public Contact · Contact
Charles W. Drescher · Principal Investigator

Providence Portland Medical Center

Portland, Oregon, 97213

Recruiting
Site Public Contact · Contact
Charles W. Drescher · Principal Investigator

Providence Saint Vincent Medical Center

Portland, Oregon, 97225

Recruiting
Site Public Contact · Contact
Charles W. Drescher · Principal Investigator

Saint Charles Health System-Redmond

Redmond, Oregon, 97756

Recruiting
Site Public Contact · Contact
Charles W. Drescher · Principal Investigator

Lehigh Valley Hospital-Cedar Crest

Allentown, Pennsylvania, 18103

Recruiting
Site Public Contact · Contact
Elie G. Dib · Principal Investigator

Lehigh Valley Hospital - Muhlenberg

Bethlehem, Pennsylvania, 18017

Recruiting
Site Public Contact · Contact
Elie G. Dib · Principal Investigator

Geisinger Medical Center

Danville, Pennsylvania, 17822

Recruiting
Site Public Contact · Contact
Joseph J. Vadakara · Principal Investigator

Pocono Medical Center

East Stroudsburg, Pennsylvania, 18301

Recruiting
Site Public Contact · Contact
Elie G. Dib · Principal Investigator

Lehigh Valley Hospital-Hazleton

Hazleton, Pennsylvania, 18201

Recruiting
Site Public Contact · Contact
Elie G. Dib · Principal Investigator

Geisinger Medical Oncology-Lewisburg

Lewisburg, Pennsylvania, 17837

Recruiting
Site Public Contact · Contact
Joseph J. Vadakara · Principal Investigator

Community Medical Center

Scranton, Pennsylvania, 18510

Recruiting
Site Public Contact · Contact
Joseph J. Vadakara · Principal Investigator

Geisinger Wyoming Valley/Henry Cancer Center

Wilkes-Barre, Pennsylvania, 18711

Recruiting
Site Public Contact · Contact
Joseph J. Vadakara · Principal Investigator

Smilow Cancer Hospital Care Center - Westerly

Westerly, Rhode Island, 02891

Recruiting
Site Public Contact · Contact
Elan Gorshein · Principal Investigator

Prisma Health Cancer Institute - Spartanburg

Boiling Springs, South Carolina, 29316

Recruiting
Site Public Contact · Contact
Suzanne R. Fanning · Principal Investigator

Prisma Health Cancer Institute - Easley

Easley, South Carolina, 29640

Recruiting
Site Public Contact · Contact
Suzanne R. Fanning · Principal Investigator

Prisma Health Cancer Institute - Butternut

Greenville, South Carolina, 29605

Recruiting
Site Public Contact · Contact
Suzanne R. Fanning · Principal Investigator

Prisma Health Cancer Institute - Faris

Greenville, South Carolina, 29605

Recruiting
Site Public Contact · Contact
Suzanne R. Fanning · Principal Investigator

Prisma Health Cancer Institute - Eastside

Greenville, South Carolina, 29615

Recruiting
Site Public Contact · Contact
Suzanne R. Fanning · Principal Investigator

Prisma Health Cancer Institute - Greer

Greer, South Carolina, 29650

Recruiting
Site Public Contact · Contact
Suzanne R. Fanning · Principal Investigator

Prisma Health Cancer Institute - Seneca

Seneca, South Carolina, 29672

Recruiting
Site Public Contact · Contact
Suzanne R. Fanning · Principal Investigator

Avera Cancer Institute-Aberdeen

Aberdeen, South Dakota, 57401

Recruiting
Site Public Contact · Contact
Xavier Andrade-Gonzalez · Principal Investigator

Sanford Cancer Center Oncology Clinic

Sioux Falls, South Dakota, 57104

Recruiting
Daniel Almquist · Principal Investigator

Avera Cancer Institute

Sioux Falls, South Dakota, 57105

Recruiting
Site Public Contact · Contact
Xavier Andrade-Gonzalez · Principal Investigator

Sanford USD Medical Center - Sioux Falls

Sioux Falls, South Dakota, 57117-5134

Recruiting
Daniel Almquist · Principal Investigator

Avera Cancer Institute at Yankton

Yankton, South Dakota, 57078

Recruiting
Site Public Contact · Contact
Xavier Andrade-Gonzalez · Principal Investigator

MD Anderson in The Woodlands

Conroe, Texas, 77384

Recruiting
Site Public Contact · Contact
Jing Christine Ye · Principal Investigator

Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center

Houston, Texas, 77030

Recruiting
Site Public Contact · Contact
Tareq Abuasab · Principal Investigator

Ben Taub General Hospital

Houston, Texas, 77030

Recruiting
Site Public Contact · Contact
Tareq Abuasab · Principal Investigator

M D Anderson Cancer Center

Houston, Texas, 77030

Recruiting
Site Public Contact · Contact
Jing Christine Ye · Principal Investigator

Michael E DeBakey VA Medical Center

Houston, Texas, 77030

Recruiting
Site Public Contact · Contact
Quillan Huang · Principal Investigator

MD Anderson West Houston

Houston, Texas, 77079

Recruiting
Site Public Contact · Contact
Jing Christine Ye · Principal Investigator

MD Anderson League City

League City, Texas, 77573

Recruiting
Site Public Contact · Contact
Jing Christine Ye · Principal Investigator

University of Texas Health Science Center at San Antonio

San Antonio, Texas, 78229

Recruiting
Site Public Contact · Contact
Matthew J. Butler · Principal Investigator

MD Anderson in Sugar Land

Sugar Land, Texas, 77478

Recruiting
Site Public Contact · Contact
Jing Christine Ye · Principal Investigator

Sovah Health Martinsville

Martinsville, Virginia, 24115

Recruiting
Site Public Contact · Contact
Ana M. Ventura · Principal Investigator

Virginia Cancer Institute

Richmond, Virginia, 23229

Recruiting
Site Public Contact · Contact
Hashim Mann · Principal Investigator

VCU Massey Cancer Center at Stony Point

Richmond, Virginia, 23235

Recruiting
Site Public Contact · Contact
Hashim Mann · Principal Investigator

Virginia Commonwealth University/Massey Cancer Center

Richmond, Virginia, 23298

Recruiting
Site Public Contact · Contact
Hashim Mann · Principal Investigator

VCU Community Memorial Health Center

South Hill, Virginia, 23970

Recruiting
Site Public Contact · Contact
Hashim Mann · Principal Investigator

Providence Regional Cancer System-Aberdeen

Aberdeen, Washington, 98520

Recruiting
Site Public Contact · Contact
Charles W. Drescher · Principal Investigator

PeaceHealth Saint Joseph Medical Center

Bellingham, Washington, 98225

Recruiting
Site Public Contact · Contact
Charles W. Drescher · Principal Investigator

Harrison Medical Center

Bremerton, Washington, 98310

Recruiting
Shahzad Siddique · Principal Investigator

Providence Regional Cancer System-Centralia

Centralia, Washington, 98531

Recruiting
Site Public Contact · Contact
Charles W. Drescher · Principal Investigator

Swedish Cancer Institute-Edmonds

Edmonds, Washington, 98026

Recruiting
Site Public Contact · Contact
Charles W. Drescher · Principal Investigator

Providence Regional Cancer Partnership

Everett, Washington, 98201

Recruiting
Site Public Contact · Contact
Charles W. Drescher · Principal Investigator

Swedish Cancer Institute-Issaquah

Issaquah, Washington, 98029

Recruiting
Site Public Contact · Contact
Charles W. Drescher · Principal Investigator

Kadlec Clinic Hematology and Oncology

Kennewick, Washington, 99336

Recruiting
Site Public Contact · Contact
Charles W. Drescher · Principal Investigator

Providence Regional Cancer System-Lacey

Lacey, Washington, 98503

Recruiting
Site Public Contact · Contact
Charles W. Drescher · Principal Investigator

PeaceHealth Saint John Medical Center

Longview, Washington, 98632

Recruiting
Site Public Contact · Contact
Charles W. Drescher · Principal Investigator

Swedish Medical Center-Ballard Campus

Seattle, Washington, 98107

Recruiting
Site Public Contact · Contact
Charles W. Drescher · Principal Investigator

Swedish Medical Center-Cherry Hill

Seattle, Washington, 98122-5711

Recruiting
Site Public Contact · Contact
Charles W. Drescher · Principal Investigator

Swedish Medical Center-First Hill

Seattle, Washington, 98122

Recruiting
Site Public Contact · Contact
Charles W. Drescher · Principal Investigator

PeaceHealth United General Medical Center

Sedro-Woolley, Washington, 98284

Recruiting
Site Public Contact · Contact
Charles W. Drescher · Principal Investigator

Providence Regional Cancer System-Shelton

Shelton, Washington, 98584

Recruiting
Site Public Contact · Contact
Charles W. Drescher · Principal Investigator

PeaceHealth Southwest Medical Center

Vancouver, Washington, 98664

Recruiting
Site Public Contact · Contact
Charles W. Drescher · Principal Investigator

Providence Saint Mary Regional Cancer Center

Walla Walla, Washington, 99362

Recruiting
Site Public Contact · Contact
Charles W. Drescher · Principal Investigator

Providence Regional Cancer System-Yelm

Yelm, Washington, 98597

Recruiting
Site Public Contact · Contact
Charles W. Drescher · Principal Investigator

West Virginia University Charleston Division

Charleston, West Virginia, 25304

Recruiting
Site Public Contact · Contact
Ahmed A. Khalid · Principal Investigator

Langlade Hospital and Cancer Center

Antigo, Wisconsin, 54409

Recruiting
Site Public Contact · Contact
Andrew J. Huang · Principal Investigator

ThedaCare Regional Cancer Center

Appleton, Wisconsin, 54911

Recruiting
Site Public Contact · Contact
Yazhini Vallatharasu · Principal Investigator

Duluth Clinic Ashland

Ashland, Wisconsin, 54806

Recruiting
Site Public Contact · Contact
Bret E. Friday · Principal Investigator

Northwest Wisconsin Cancer Center

Ashland, Wisconsin, 54806

Recruiting
Site Public Contact · Contact
Bret E. Friday · Principal Investigator

Marshfield Clinic-Chippewa Center

Chippewa Falls, Wisconsin, 54729

Recruiting
Seth O. Fagbemi · Principal Investigator

Marshfield Medical Center-EC Cancer Center

Eau Claire, Wisconsin, 54701

Recruiting
Seth O. Fagbemi · Principal Investigator

Essentia Health-Hayward Clinic

Hayward, Wisconsin, 54843

Recruiting
Site Public Contact · Contact
Bret E. Friday · Principal Investigator

Gundersen Lutheran Medical Center

La Crosse, Wisconsin, 54601

Recruiting
Site Public Contact · Contact
David E. Marinier · Principal Investigator

Marshfield Clinic - Ladysmith Center

Ladysmith, Wisconsin, 54848

Recruiting
Seth O. Fagbemi · Principal Investigator

Marshfield Medical Center-Marshfield

Marshfield, Wisconsin, 54449

Recruiting
Seth O. Fagbemi · Principal Investigator

Aspirus Medford Hospital

Medford, Wisconsin, 54451

Recruiting
Site Public Contact · Contact
Andrew J. Huang · Principal Investigator

Marshfield Clinic-Minocqua Center

Minocqua, Wisconsin, 54548

Recruiting
Seth O. Fagbemi · Principal Investigator

Marshfield Medical Center - Neillsville

Neillsville, Wisconsin, 54456

Recruiting
Seth O. Fagbemi · Principal Investigator

Cancer Center of Western Wisconsin

New Richmond, Wisconsin, 54017

Recruiting
Site Public Contact · Contact
David M. King · Principal Investigator

Ascension Saint Mary's Hospital

Rhinelander, Wisconsin, 54501

Recruiting
Site Public Contact · Contact
Andrew J. Huang · Principal Investigator

Marshfield Medical Center-Rice Lake

Rice Lake, Wisconsin, 54868

Recruiting
Seth O. Fagbemi · Principal Investigator

Essentia Health-Spooner Clinic

Spooner, Wisconsin, 54801

Recruiting
Site Public Contact · Contact
Bret E. Friday · Principal Investigator

Ascension Saint Michael's Hospital

Stevens Point, Wisconsin, 54481

Recruiting
Site Public Contact · Contact
Andrew J. Huang · Principal Investigator

Marshfield Medical Center-River Region at Stevens Point

Stevens Point, Wisconsin, 54482

Recruiting
Seth O. Fagbemi · Principal Investigator

Essentia Health Saint Mary's Hospital - Superior

Superior, Wisconsin, 54880

Recruiting
Site Public Contact · Contact
Bret E. Friday · Principal Investigator

Aspirus Regional Cancer Center

Wausau, Wisconsin, 54401

Recruiting
Site Public Contact · Contact
Andrew J. Huang · Principal Investigator

Marshfield Clinic-Wausau Center

Wausau, Wisconsin, 54401

Recruiting
Seth O. Fagbemi · Principal Investigator

Marshfield Medical Center - Weston

Weston, Wisconsin, 54476

Recruiting
Seth O. Fagbemi · Principal Investigator

Aspirus Cancer Care - Wisconsin Rapids

Wisconsin Rapids, Wisconsin, 54494

Recruiting
Site Public Contact · Contact
Andrew J. Huang · Principal Investigator

Marshfield Clinic - Wisconsin Rapids Center

Wisconsin Rapids, Wisconsin, 54494

Recruiting
Seth O. Fagbemi · Principal Investigator